
Deadline for research LOIs extended to November 17 at 11:59 PM ET
UPDATE: Deadline extended to November 17 at 11:59 PM ET. Thanks to the generous support of our patients, families, caregivers, corporate supporters, and the many
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.

UPDATE: Deadline extended to November 17 at 11:59 PM ET. Thanks to the generous support of our patients, families, caregivers, corporate supporters, and the many

A group of patients joins the patient panel at the 2023 International Symposium on Malignant Mesothelioma to discuss their experiences of diagnosis, finding an expert

Joseph George, RN, Memorial Sloan Kettering Cancer Center presents at the 2023 International Symposium on Malignant Mesothelioma on palliative symptom management in patients with mesothelioma.

Making an impact on mesothelioma research, education, support and advocacy can include a variety of ways depending on a supporter’s comfort level and ability. Mackenzie

Lawyers Joseph Belluck of Belluck & Fox, and Dawn Besserman of MRHFM discuss legal issues surrounding a mesothelioma diagnosis. Moderated by Cheryl Bruner. https://youtu.be/JbP7hZPMyoA This is

Julie White, RN, OCN is an experienced oncology nurse with 18 years in the field. She holds a Bachelor of Science in Nursing and is

Peritoneal mesothelioma can be treated surgically (i.e. HIPEC) and/or systemically (chemotherapy or immunotherapy). This session features two medical oncologists and three peritoneal mesothelioma surgeons as

Genetic mutations coupled with environmental factors can lead to the development of cancer, including mesothelioma. Some of those mutations have prognostic implications, while others may